Quad Capital Management Advisors’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quad Capital Management Advisors's KITE Position: Q4 2017 in Review
Quad Capital Management Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 192,537 shares — an estimated $34.6M sold.
Quad Capital Management Advisors first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $34.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Quad Capital Management Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Quad Capital Management Advisors sold 192,537 Kite Pharma, Inc. shares in Q4 2017, an estimated $34.6M.
- Quad Capital Management Advisors first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
- Quad Capital Management Advisors's Kite Pharma, Inc. position peaked at $34.6M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Quad Capital Management Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.